Product
rimiducid
1 clinical trial
2 indications
Indication
Acute Myeloid LeukemiaIndication
Myelodysplastic SyndromesClinical trial
A Randomized Phase II/III Study of αβ T Cell-Depleted, Related, Haploidentical Hematopoietic Stem Cell Transplant (Haplo-HSCT) Plus Rivogenlecleucel vs. Haplo-HSCT Plus Post-Transplant Cyclophosphamide (PTCy) in Patients With AML or MDSStatus: Terminated, Estimated PCD: 2019-07-23